Dr. Stephen A. Cutler, Ph.D., is Group President Clinical Research Services of Icon PLC., since November 2011. Prior to joining the Company Dr. Cutler held the position of Chief Executive Officer of Kendle, having previously served as Chief Operating Officer. Prior to Kendle, Dr. Cutler spent 14 years with Quintiles where he served as Senior Vice President, Global Project Management; Senior Vice President, Clinical, Medical and Regulatory; Senior Vice President, Project Management Europe; and Vice President, Oncology Europe as well as regional leadership positions in South Africa and Australia. Prior to joining Quintiles Dr. Cutler held positions with Sandoz in Australia and Europe. He holds a B.Sc. and a Ph.D from the University of Sydney and a Masters of Business Administration from the University of Birmingham .
The company has return on total asset (ROA) of 4.74 % which means that it generated profit of $4.74 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 8.91 % meaning that it created $8.91 on every $100 dollars invested by stockholders.
The company currently holds 20 M in liabilities with Debt to Equity (D/E) ratio of 0.03 which may suggest the company is not taking enough advantage from borrowing. ICON Public Limited Company has Current Ratio of 1.5 which is within standard range for the sector.
ICON Public Limited Company, a contract research organization, offer outsourced development services to the pharmaceutical, biotechnology, and medical device industries primarily in Ireland, the United States, and rest of Europe. ICON Public Limited Company [ICLR] is traded on NASDAQ in USA. It is located in Dublin, and employs 10,200 people. Filter other
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory